# Mickey Kertesz

> Mickey Kertesz is an Israeli scientist and entrepreneur based in Menlo Park. A computer scientist who moved into computational biology, he co-founded Moleculo, which Illumina acquired in late 2012, and Karius in 2014. He served as Karius CEO until October 2020, then became president and chief product officer. He is now CEO and founder of Dinamo Biotechnologies.

- **Role:** CEO and Founder at Dinamo Biotechnologies
- **Organizations:** Dinamo Biotechnologies, Karius, Moleculo, Illumina, Stanford University
- **Nationality:** Israeli
- **Education:** M.S. in Computer Science, Tel Aviv University, Ph.D. in Computational Biology, Weizmann Institute of Science, Postdoctoral research in Bioengineering (not a degree), Stanford University
- **Known for:** Co-founded Moleculo and led it through acquisition by Illumina., Co-founded Karius in 2014 and led its early commercialization., Served as Karius CEO during its $165 million Series B financing.

## Career timeline

- **—** — Served as a pilot in the Israeli Air Force; subsequently studied computer science.
- **—** — Worked for approximately seven years in image processing at startups before moving into computational biology.
- **2011** — Co-founded Moleculo from Stanford research with Dmitry Pushkarev and scientific co-founder Stephen Quake; accounts differ between late-2011 founding and January-2012 incorporation.
- **2012** — Moleculo received investment from True Ventures and was acquired by Illumina in late 2012.
- **2013** — Illumina publicly announced the Moleculo acquisition in January.
- **2014** — Co-founded Karius with Tim Blauwkamp and Stephen Quake.
- **2020** — Karius announced a $165 million Series B round in February while Kertesz was CEO.
- **2020** — Transitioned to Karius president and chief product officer on October 6 as Alec Ford became CEO.
- **2026** — Identified as Dinamo Biotechnologies CEO in a March 26 public document.

## Achievements

- Co-founded Moleculo and led it through acquisition by Illumina.
- Co-founded Karius in 2014 and led its early commercialization.
- Served as Karius CEO during its $165 million Series B financing.
- Introduced True Ventures to founders behind its second and third investments in the field.

## Latest updates

- **2026-03** — A public document dated March 26 identifies Mickey Kertesz as Dinamo Biotechnologies CEO.
- **2026-02** — A Prezi presentation attributed to Mickey Kertesz was updated February 5, 2026.

## Links

- LinkedIn: https://www.linkedin.com/in/mickey-kertesz-654b3
- Twitter/X: https://twitter.com/MickeyKertesz

---

Profile page: https://yespress.io/mickey-kertesz
Published by YesPress — https://yespress.io
Last updated: 2026-10-11